Print Page

Products found to contain undeclared medicines

The United States: Kiriko, LLC. issues voluntary nationwide recall of A1 Slim due to undeclared sibutramine, phenolphthalein and N-desmethyl sibutramine
The US Food and Drug Administration (FDA) announces that Kiriko, LLC. is voluntarily recalling all lots of A1 Slim 30 capsules bottle to the consumer level. FDA laboratory analysis has found the A1 Slim product to be tainted with sibutramine, phenolphthalein and N-desmethyl sibutramine. This tainted product is marketed as a weight loss dietary supplement.

Sibutramine is an appetite suppressant that was withdrawn from the US market in October 2010 due to safety concerns. N-desmethyl sibutramine is an active metabolite of sibutramine. Sibutramine and its active metabolites substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Phenolphthalein was previously used in over-the-counter laxatives, but because of concerns of carcinogenicity, it is no longer marketed in the US. To date, Kiriko, LLC. has not received any reports of adverse events related to this recall.

Please refer to the following website in FDA for details:

In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by FDA, and was posted on the Drug Office website on 4 Oct 2017.

Ends/Saturday, Oct 7, 2017
Issued at HKT 12:00
Related Information:
The United Stated: Public Notification: A1 Slim contains hidden drug ingredients... Posted 2017-10-04